Gabapentin Capsule
Product Images NDC 60760-846

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Gabapentin (NDC 60760-846). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by St. Mary's Medical Park Pharmacy, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Formula (66c3584b 21d1 450a 8bfe Ba096129b91a 01)

Illustration showing the formula for creatinine clearance (CLCr) calculation. The formula accounts for patient age (years), weight (kg), serum creatinine (mg/dL), with an adjustment factor of 0.85 for female patients.*

FDA Label Image

Figure1 (66c3584b 21d1 450a 8bfe Ba096129b91a 02)

Chemical structure of gabapentin, showing a cyclohexane ring attached to a central carbon bonded to an amine group (CH2NH2) and a carboxylic acid group (CH2CO2H).*

FDA Label Image

Image 1 (66c3584b 21d1 450a 8bfe Ba096129b91a 03)

A line graph comparing mean pain scores over an 8-week period between placebo and Gabapentin 3600 mg/day groups. The x-axis represents weeks, divided into a 4-week dose titration period and a 4-week fixed dose period. Gabapentin group shows a decreasing pain score trend, while placebo remains relatively stable.*

FDA Label Image

Image 2 (66c3584b 21d1 450a 8bfe Ba096129b91a 04)

A line graph depicting mean pain scores over a 7-week period, comparing placebo with Gabapentin dosed at 1800 mg/day and 2400 mg/day. The x-axis represents weeks including a 3-week dose titration period followed by a 4-week fixed dose period. The y-axis indicates mean pain scores from 0 to 10.*

FDA Label Image

Image 3 (66c3584b 21d1 450a 8bfe Ba096129b91a 05)

A bar chart titled 'Figure 3. Proportion of Responders (patients with a 50% reduction in pain score) at Endpoint: Controlled PHN Studies.' It compares the percentage of responders for placebo (PBO) and two different dosages of Gabapentin (GBP 3600 for Study 1 and GBP 1800, GBP 2400 for Study 2). The chart shows percentages of responders for each group across two separate studies.*

FDA Label Image

Image 4 (66c3584b 21d1 450a 8bfe Ba096129b91a 06)

A scatter plot chart depicting the relationship between daily dose in milligrams (600 to 1800 mg) on the x-axis and difference percentage on the y-axis (ranging from 2% to 22%). The chart includes data points from three studies labeled as Study a, Study b, and Study c, displayed with distinct markers and annotations next to each point.*

FDA Label Image

60760-846 (Gabapentin 60760 846 60)

The label is for Gabapentin capsules, USP 400 mg, with a quantity of 60 capsules. The product is labeled with NDC 60760-846-60 and manufactured by St. Mary's Medical Park Pharmacy, Oro Valley, AZ. The label includes a barcode, placeholder text for RX number, lot number, and expiration date, as well as storage instructions to store at 20°-25°C (68°-77°F) and a note to use as directed.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.